Kowalski A, Nowak P, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3907590 A1, 2021-05-26.
Klinger H, Anderson J P, Lee S K. "Method for the Synthesis of 6,7-Dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one" [P]. US Patent, US 11921969 B2, 2020-07-02.
发明人杨光,马晓峰,王建平. "A Process for Preparing High-Purity 6,7-Dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one" [P]. 中国发明专利, 专利号 CN 110242121 B, 授权公告日 2023-11-19.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2017, 2013, (8), 4755-4767.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2016, 1495, (1), 6802-6815.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 6,7-Dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one Using HRMS and NMR". J. Sep. Sci., 2011, 1240, 1734-1754.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2010, 390, 5488-5495.